Jennifer Haldeman

J.D. Haldeman has extensive experience in various leadership and executive roles in the pharmaceutical and healthcare industry. Jennifer "J.D." currently serves as the Vice President, Commercial at Immunicom, Inc. Prior to this, they were the Vice President of Marketing & Corporate Communications at Biora Therapeutics from July 2020 to August 2021.

Jennifer "J.D."'sprevious roles include Executive Vice President of Marketing, Sales & Corporate Communications at MedVantx from 2011 to 2014, Chief Commercial Officer at Zogenix, Inc. from 2006 to 2010, and Vice President of Marketing at InterMune from June 2004 to December 2005.

Jennifer "J.D." also held the position of Vice President of Marketing & Commercial Analytics at Prometheus Laboratories Inc. from April 2003 to March 2004, Vice President of Marketing & Business Development at Tandem Medical from 2000 to 2003, and Vice President of Commercial Development & Investor Relations at Shaman Pharmaceuticals from 1997 to 1999.

J.D. Haldeman began their career at Pfizer in 1988, where they held various sales and marketing positions, including Senior Director of Cardiovasculars and Product Manager of Neurontin, before leaving the company in June 1997.

Jennifer "J.D." Haldeman has a BA degree in Philosophy, with minors in Biology and Chemistry, from Brigham Young University. Jennifer "J.D." also holds an MBA degree from Northwestern University - Kellogg School of Management, with a focus on Marketing, Finance, and International Business. In addition, they have a Master of Business Administration degree with a specialization in International Marketing and Finance from Erasmus University Rotterdam. Jennifer "J.D."'sgeneral education was completed at TASIS-Switzerland.